Hepatitis C in Nepal — Testing, Treatment & Cure A Curable Infection — Testing, Modern Antivirals & Follow-Up
Hepatitis C at Thamel Clinic — testing, modern antiviral treatment that cures most patients, and follow-up that confirms cure.
Medically Reviewed Content
Reviewed by: STD Specialist (MBBS, MD - Medicine)
Last medical review: June 1, 2026
Next scheduled review: December 1, 2026
This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.
Hepatitis C — What to Know
- Hepatitis C is curable: direct-acting antivirals cure most patients.
- Antibody screens, RNA confirms: the two-step pathway.
- Screening matters: at-risk groups should be screened.
Hepatitis C in Nepal
- Blood-borne — transmission through transfusion, injection equipment, unsafe procedures, and certain sexual contexts.
- Mostly silent — most chronic HCV is asymptomatic until late; testing finds it.
- Curable now — DAA treatment cures most patients in ~12 weeks.
- Risk-group aware — people who inject drugs and certain exposure histories warrant targeted screening.
Hepatitis C — a Now-Curable Infection
Hepatitis C is a viral infection of liver transmitted primarily by blood — historically through transfusion, injection equipment and unsafe procedures, and also sexually in certain contexts. Most acute infections are silent or mildly nonspecific; disease reveals itself years later as chronic liver disease when silent infection has had time to damage liver.
The crucial fact: hepatitis C is now curable. Modern direct-acting antivirals (DAAs) cure large majority of patients in ~12 weeks of treatment — sustained virological response at ~12 weeks post-treatment is definition of cure. This is a different infection from hepatitis B, which is monitored or treated long-term rather than cured.
What pathway looks like: screening by anti-HCV antibody, confirmatory HCV RNA testing to establish whether infection is active, liver assessment to stage any damage, treatment with a DAA course, and follow-up testing to confirm cure. Each step is straightforward; pathway is what turns a blood-borne infection into a resolved one.
This page covers Hepatitis C in Nepal in Kathmandu — confidential, non-judgmental care. Correct evaluation comes first: the actual condition or need determines which approach is appropriate, and the plan is matched to the real cause rather than generic advice. Hepatitis C is caused by HCV — a blood-borne virus causing chronic liver infection. It is diagnosed by HCV antibody screening plus RNA confirmation; treated with direct-acting antivirals that cure most patients. Screening is recommended for at-risk groups.
How Hepatitis C Spreads
HCV is blood-borne: transfusion of unscreened blood, shared injection equipment ( dominant route in people who inject drugs), unsafe medical or tattooing equipment, and less commonly through sexual contact — sexual route is real but less efficient than for HIV or hepatitis B, and matters more in specific contexts (HIV co-infection, traumatic sex, certain higher-risk practices).
The transmission pattern explains screening logic: highest-yield screening is in people with blood-exposure histories — transfusion before screening was universal, injection drug use, occupational exposure, or partners of diagnosed patients — rather than indiscriminate population screening.
Blood-Borne
Transfusion, injection equipment, unsafe procedures.
Injection Drug Use
The dominant transmission route — targeted screening matters most here.
Sexual Transmission
Real but less efficient than HIV/HBV — context-dependent.
Risk-Based Screening
Exposure history guides who benefits most from testing.
Testing & Diagnosis
The pathway is two-step: a screening anti-HCV antibody test detects whether you have been exposed; a confirmatory HCV RNA test establishes whether infection is currently active. This matters because a positive antibody can mean either active infection or a past infection that cleared — the RNA distinguishes them.
Alongside confirmation, liver assessment stages damage: liver function tests (ALT/AST), ultrasound where indicated, and non-invasive fibrosis assessment. The staging guides urgency and treatment plan — established cirrhosis changes management.
Anti-HCV Screen
Detects exposure — positive means past or current infection.
HCV RNA Confirmation
Establishes whether infection is currently active.
Liver Assessment
ALT/AST and fibrosis staging — damage picture.
Stage-Dependent
Cirrhosis changes management — staging matters.
Treatment — the Curable Reality
Direct-acting antivirals cure large majority of hepatitis C patients — typically an ~8–12 week oral course depending on genotype and stage. SVR12 — sustained virological response 12 weeks after treatment ends — is standard definition of cure.
Treatment is accessible and well-tolerated for most patients; considerations are stage (cirrhosis changes management and post-cure monitoring), co-infection (HIV/HBV co-infection is managed together), and post-cure point that cure does not prevent reinfection — ongoing exposure can re-infect.
DAA Treatment
~8–12 week oral course — cures large majority.
SVR12 = Cure
Sustained virological response at 12 weeks post-treatment.
Stage Matters
Cirrhosis changes management and post-cure monitoring.
Reinfection Possible
Cure does not prevent reinfection — ongoing exposure matters.
Follow-Up & Prevention
Follow-up confirms cure — SVR12 testing — and monitors liver where damage was established (cured cirrhosis still needs ongoing surveillance). Associated infections are screened: hepatitis B and HIV testing is standard alongside HCV because exposure routes overlap.
There is no hepatitis C vaccine — prevention is exposure reduction: not sharing injection equipment, safe procedures and tattooing, and informed precautions for sexual transmission contexts. Partner testing is discussed where relevant.
SVR12 Confirmation
The follow-up test that proves cure.
Post-Cure Surveillance
Established cirrhosis still needs monitoring after cure.
Associated Screening
HBV and HIV tested alongside — overlapping routes.
No Vaccine
Prevention is exposure reduction — no vaccine exists.
Hepatitis C in Nepal
The virus
Hepatitis C virus — blood-borne transmission.
Screening
HCV antibody — the screening test.
Confirmation
HCV RNA — confirms active infection.
Cure
Direct-acting antivirals — cure most patients.
Hepatitis C Services & Costs
| Service | What It Includes | Cost (NPR) |
|---|---|---|
| Consultation | Risk assessment and testing guidance | Rs. 450 |
| Anti-HCV screen | Exposure screening | Lab rate |
| HCV RNA | Confirmatory active-infection testing | Lab rate |
| Treatment | DAA course with liver assessment | Per case |
Transparent pricing; confirm when booking.
Why Thamel Clinic for Hepatitis C
- Two-step testing — screen then confirm; a positive antibody is not a diagnosis of active infection.
- Curable framing — DAA treatment resolves most cases; stated honestly.
- Stage-aware — cirrhosis and co-infection managed properly.
- Complete follow-up — SVR12 confirmation and post-cure surveillance.
- Confidential — private testing, treatment and results.
Frequently Asked Questions
Is hepatitis C curable?
Yes — modern direct-acting antivirals cure large majority in ~8–12 weeks; SVR12 confirms cure.
How is hepatitis C different from hepatitis B?
HCV is curable; HBV is managed long-term. They are different viruses with different management.
How did I get hepatitis C?
Blood-borne — transfusion, injection equipment, unsafe procedures, or certain sexual contexts; history identifies likely route.
Does a positive test mean I have it?
A positive antibody means exposure — active infection is confirmed by HCV RNA, which distinguishes past from current infection.
Do I need to tell my partner?
Where sexual route is relevant — discuss at consultation; partner testing is advised case-by-case.
Is there a vaccine?
No — there is no HCV vaccine; prevention is exposure reduction.
Is hepatitis C curable?
Yes — direct-acting antivirals cure most patients; the cure rate exceeds 95%.
How is hepatitis C diagnosed?
HCV antibody screening plus HCV RNA confirmation — antibody screens, RNA confirms active infection.
Still have questions? Contact us or book an appointment for personalized guidance.
Related Services & Guides
Related Health Guides
Medical Disclaimer
Important information about using this medical website
Educational Purpose Only
The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
No Doctor-Patient Relationship
Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Emergency Situations
If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.
Emergency Contact Information:
National Emergency:
102 (Ambulance)
Our Clinic:
+977-9700682800 (WhatsApp available 24/7)
Bir Hospital Emergency:
+977-1-4412400
TU Teaching Hospital:
+977-1-4434320
Timeliness of Information
Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.
Professional Medical Advice Required
Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.
Treatment and Diagnosis
Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.
Limitation of Liability
In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.
Nepal-Specific Considerations
This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.
Last Updated: November 7, 2026 |Clinic: Thamel Clinic |Licensed: Registered